GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinium Pharmaceuticals Inc (STU:7AY1) » Definitions » Price-to-Tangible-Book

Actinium Pharmaceuticals (STU:7AY1) Price-to-Tangible-Book : 5.96 (As of May. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Actinium Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-05), Actinium Pharmaceuticals's share price is €8.185. Actinium Pharmaceuticals's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was €1.37. Hence, Actinium Pharmaceuticals's Price to Tangible Book Ratio of today is 5.96.

The historical rank and industry rank for Actinium Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

STU:7AY1' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.53   Med: 3.89   Max: 83.68
Current: 6.01

During the past 13 years, Actinium Pharmaceuticals's highest Price to Tangible Book Ratio was 83.68. The lowest was 1.53. And the median was 3.89.

STU:7AY1's Price-to-Tangible-Book is ranked worse than
77.33% of 1222 companies
in the Biotechnology industry
Industry Median: 2.715 vs STU:7AY1: 6.01

A closely related ratio is called PB Ratio. As of today, Actinium Pharmaceuticals's share price is €8.185. Actinium Pharmaceuticals's Book Value per Sharefor the quarter that ended in Mar. 2024 was €1.37. Hence, Actinium Pharmaceuticals's P/B Ratio of today is 5.96.


Actinium Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Actinium Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinium Pharmaceuticals Price-to-Tangible-Book Chart

Actinium Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.92 2.45 1.77 3.91 3.65

Actinium Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 3.53 3.83 3.65 5.54

Competitive Comparison of Actinium Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Actinium Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actinium Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinium Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Actinium Pharmaceuticals's Price-to-Tangible-Book falls into.



Actinium Pharmaceuticals Price-to-Tangible-Book Calculation

Actinium Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=8.185/1.373
=5.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Actinium Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Actinium Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinium Pharmaceuticals (STU:7AY1) Business Description

Traded in Other Exchanges
Address
275 Madison Avenue, 7th Floor, New York, NY, USA, 10016
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Actinium Pharmaceuticals (STU:7AY1) Headlines

No Headlines